Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial design, with conditions such as A, B, A and B, or none. This results in a two-way nested design. The usual issue of sample size and power now arises for various clinically relevant contrast hypotheses. Assuming a fixed total sample size at each level (number of clusters or centers, number of patients), we derive the optimal proportion of the total sample to be allocated to each treatment arm. We consider treatment assignment first at the highest level (cluster randomized trial) and then at the lowest level (multicenter trial). We derive the optimal allocation ratio for various sets of clinically relevant hypotheses. We then evaluate the efficie...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
At the design stage of a study, it is crucial to compute the sample size needed for treatment effect...
At the design stage of a study, it is crucial to compute the sample size needed for treatment effect...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
Cluster randomized and multicenter trials sometimes combine two treatments A and B in a factorial de...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
The usual treatment allocation in randomized trials and their factorial and nested extensions is bal...
At the design stage of a study, it is crucial to compute the sample size needed for treatment effect...
At the design stage of a study, it is crucial to compute the sample size needed for treatment effect...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...
Typically, clusters and individuals in cluster randomized trials are allocated across treatment cond...